---
title: "Mr Kiren Lee Naidoo — Ownership Dossier"
canonical: https://whiteintel.dev/entity/cebdd081-0af5-4e2b-bdcc-641c5b0b018e
json: https://whiteintel.dev/api/public/dossier/cebdd081-0af5-4e2b-bdcc-641c5b0b018e
identifier: psc:w6aF0snfQWKuAZWUemkF0sR6tCE
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Mr Kiren Lee Naidoo

**Type:** Person  
**Jurisdiction:** GB  
**Identifier:** `psc:w6aF0snfQWKuAZWUemkF0sR6tCE`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/cebdd081-0af5-4e2b-bdcc-641c5b0b018e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/cebdd081-0af5-4e2b-bdcc-641c5b0b018e  

## Ownership & control

### Holdings / subsidiaries

- **FRONTIER BIOPHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bdb14c6a-2ae4-5d63-9a6b-3edb9e19f7c0

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Mr Kiren Lee Naidoo**. Human view: https://whiteintel.dev/entity/cebdd081-0af5-4e2b-bdcc-641c5b0b018e · Structured JSON: https://whiteintel.dev/api/public/dossier/cebdd081-0af5-4e2b-bdcc-641c5b0b018e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._